Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Zollinger-Ellison syndrome: presentation, response to therapy, and outcome.

Wilcox CM, Seay T, Arcury JT, Mohnen J, Hirschowitz BI.

Dig Liver Dis. 2011 Jun;43(6):439-43. doi: 10.1016/j.dld.2010.11.007. Epub 2010 Dec 30.

PMID:
21193359
2.

Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors.

Wilcox CM, Seay T, Arcury J, Hirschowitz BI.

Scand J Gastroenterol. 2011 Mar;46(3):277-80. doi: 10.3109/00365521.2010.536255. Epub 2010 Nov 15.

PMID:
21073392
3.

Costs and risks in the management of patients with gastric acid hypersecretion.

Hirschowitz BI, Fineberg N, Wilcox CM, Mohnen J, Worthington J.

J Clin Gastroenterol. 2010 Jan;44(1):28-33. doi: 10.1097/MCG.0b013e3181a59aa5.

PMID:
19581810
4.

Treatment strategies for Zollinger-Ellison syndrome.

Wilcox CM, Hirschowitz BI.

Expert Opin Pharmacother. 2009 May;10(7):1145-57. doi: 10.1517/14656560902887035 . Review.

PMID:
19351273
5.

Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole.

Wilcox CM, Martin T, Phadnis M, Mohnen J, Worthington J, Hirschowitz BI.

BMC Gastroenterol. 2008 May 28;8:18. doi: 10.1186/1471-230X-8-18.

6.

Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.

Hirschowitz BI, Worthington J, Mohnen J.

Aliment Pharmacol Ther. 2008 Jun 1;27(11):1110-21. doi: 10.1111/j.1365-2036.2008.03658.x. Epub 2008 Feb 27.

7.

Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.

Hirschowitz BI, Worthington J, Mohnen J, Haber M.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):869-78.

8.

Comparison of 13C- urea blood test to 13C-breath test and rapid urease test for the diagnosis of Helicobacter pylori infection.

Fry LC, Curioso WH, Rickes S, Horton G, Hirschowitz BI, Mönkemüller K.

Acta Gastroenterol Latinoam. 2005;35(4):225-9.

PMID:
16496854
9.

Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.

Hirschowitz BI, Simmons J, Mohnen J.

Clin Gastroenterol Hepatol. 2005 Jan;3(1):39-48.

PMID:
15645403
10.

Risk factors for esophagitis in extreme acid hypersecretors with and without Zollinger-Ellison syndrome.

Hirschowitz BI, Simmons JL, Johnson LF, Mohnen J.

Clin Gastroenterol Hepatol. 2004 Mar;2(3):220-9.

PMID:
15017606
11.

Usual and unusual causes of duodenal ulcer.

Hirschowitz BI.

Dig Liver Dis. 2003 Aug;35(8):519-22. Review. No abstract available.

PMID:
14567453
12.

Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse.

Hirschowitz BI, Lanas A.

J Clin Gastroenterol. 2002 May-Jun;34(5):523-8.

PMID:
11960062
13.
14.
15.

Pernicious anemia and stomach cancer.

Hirschowitz BI.

Scand J Gastroenterol. 2001 Aug;36(8):896. No abstract available.

PMID:
11495089
16.

Questions regarding future research on aspirin and the gastrointestinal tract.

Hirschowitz BI, Hawkey CJ.

Am J Med. 2001 Jan 8;110(1A):74S-78S. Review.

PMID:
11166004
18.

Endoscopy--40 years since fiber optics. Any light at the end of the tunnel?

Hirschowitz BI.

Dig Surg. 2000;17(2):115-7. No abstract available.

PMID:
10781971
19.

Pepsin and the esophagus.

Hirschowitz BI.

Yale J Biol Med. 1999 Mar-Jun;72(2-3):133-43. Review.

20.

Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.

Lanas A, Remacha B, Sáinz R, Hirschowitz BI.

Am J Gastroenterol. 2000 Feb;95(2):513-9.

PMID:
10685760
21.

Surgery to cure the Zollinger-Ellison syndrome.

Hirschowitz BI.

N Engl J Med. 1999 Dec 30;341(27):2096-7. No abstract available.

PMID:
10627201
22.

Minimizing the risk of NSAID-induced GI bleeding.

Hirschowitz BI.

Cleve Clin J Med. 1999 Oct;66(9):524-7. Review.

23.

Association of obesity with hiatal hernia and esophagitis.

Wilson LJ, Ma W, Hirschowitz BI.

Am J Gastroenterol. 1999 Oct;94(10):2840-4.

PMID:
10520831
24.

Clinical aspects of ECL-cell abnormalities.

Hirschowitz BI.

Yale J Biol Med. 1998 May-Aug;71(3-4):303-10. Review.

25.

Toxicity of NSAIDs in the stomach and duodenum.

Lanas A, Hirschowitz BI.

Eur J Gastroenterol Hepatol. 1999 Apr;11(4):375-81. Review.

PMID:
10321752
26.
27.
28.

Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

Sontag SJ, Robinson M, Roufail W, Hirschowitz BI, Sabesin SM, Wu WC, Behar J, Peterson WL, Kranz KR, Tarnawski A, Dayal Y, Berman R, Simon TJ.

Aliment Pharmacol Ther. 1997 Apr;11(2):373-80.

29.

Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management.

Hirschowitz BI.

Am J Gastroenterol. 1997 Apr;92(4 Suppl):44S-48S; discussion 49S-50S. Review.

PMID:
9127626
30.

Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use.

Lanas AI, Arroyo MT, Esteva F, Cornudella R, Hirschowitz BI, Sáinz R.

Gut. 1996 Nov;39(5):654-60.

31.
32.

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.

Hirschowitz BI, Mohnen J, Shaw S.

Aliment Pharmacol Ther. 1996 Aug;10(4):507-22.

PMID:
8853754
33.

Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.

Hirschowitz BI, Mohnen J, Shaw S.

Aliment Pharmacol Ther. 1996 Aug;10(4):497-506.

PMID:
8853753
34.
35.

Management of refractory and complicated reflux esophagitis.

Hirschowitz BI.

Yale J Biol Med. 1996 May-Jun;69(3):271-81. Review.

36.

Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs.

Day JP, Lanas A, Rustagi P, Hirschowitz BI.

J Clin Gastroenterol. 1996 Mar;22(2):96-103.

PMID:
8742645
37.

Nonsteroidal anti-inflammatory drugs and the gut.

Hirschowitz BI.

South Med J. 1996 Mar;89(3):259-63. Review.

PMID:
8604453
38.

Pharmacological aspects of acid secretion.

Hirschowitz BI, Keeling D, Lewin M, Okabe S, Parsons M, Sewing K, Wallmark B, Sachs G.

Dig Dis Sci. 1995 Feb;40(2 Suppl):3S-23S. Review.

PMID:
7859583
39.

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.

Hirschowitz BI.

Gastroenterologist. 1994 Sep;2(3):207-23. Review.

PMID:
7987619
40.

Effects of cholinergic, histaminergic, and peptidergic stimulation on pepsinogen secretion by isolated human peptic cells.

Lanas AI, Anderson JW, Uemura N, Hirschowitz BI.

Scand J Gastroenterol. 1994 Aug;29(8):678-83.

PMID:
7973426
41.

The cost of doing business: occupational hazards for endoscopists.

Hirschowitz BI.

Endoscopy. 1994 Aug;26(6):559-61. Review. No abstract available.

PMID:
7828571
42.

Medical management of esophageal reflux.

Hirschowitz BI.

Yale J Biol Med. 1994 May-Aug;67(3-4):223-31. Review.

43.

Ingestion of aspirin prevents platelet-induced human fibroblast growth. Implications for peptic ulcer healing.

Lanas A, Haggerty P, Hirschowitz BI.

Scand J Gastroenterol. 1994 Jan;29(1):17-22.

PMID:
8128171
44.

[Non-steroid anti-inflammatory agents and digestive tract lesions].

Lanas Arbeloa AI, Hirschowitz BI.

Rev Esp Enferm Dig. 1993 Nov;84(5):326-35. Review. Spanish. No abstract available.

PMID:
8305260
45.

Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls.

Hirschowitz BI, Groarke J.

Dig Dis Sci. 1993 Oct;38(10):1874-84.

PMID:
8404408
46.

Development and application of endoscopy.

Hirschowitz BI.

Gastroenterology. 1993 Feb;104(2):337-42. No abstract available.

PMID:
8425675
47.

Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.

Hirschowitz BI.

Yale J Biol Med. 1992 Nov-Dec;65(6):659-76; discussion 689-92. Review.

48.

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding.

Lanas A, Sekar MC, Hirschowitz BI.

Gastroenterology. 1992 Sep;103(3):862-9.

PMID:
1499936
49.
50.

Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy.

Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW.

Gastroenterology. 1992 Apr;102(4 Pt 1):1409-18.

PMID:
1551550

Supplemental Content

Loading ...
Support Center